Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 67
TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192452(US9187466, 50 | US9687476, 50)
Affinity DataIC50: 1.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)
Affinity DataIC50: 1.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)
Affinity DataIC50: 2nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192468(US9187466, 110 | US9687476, 110 | US10800746, Exam...)
Affinity DataIC50: 3.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50: 4nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)
Affinity DataIC50: 4.20nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192467(US9187466, 101 | US9687476, 101 | US10800746, Exam...)
Affinity DataIC50: 4.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192473(US9187466, 132 | US9687476, 132)
Affinity DataIC50: 4.60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192474(US9187466, 135 | US9687476, 135)
Affinity DataIC50: 5.80nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192468(US9187466, 110 | US9687476, 110 | US10800746, Exam...)
Affinity DataIC50: 6.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192453(US9187466, 54 | US9687476, 54 | US10800746, Exampl...)
Affinity DataIC50: 6.80nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192469(US9187466, 111 | US9687476, 111)
Affinity DataIC50: 7.70nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 8.30nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192466(US9187466, 96 | US9687476, 96)
Affinity DataIC50: 8.40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192453(US9187466, 54 | US9687476, 54 | US10800746, Exampl...)
Affinity DataIC50: 8.5nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192449(US9187466, 32 | US9687476, 32)
Affinity DataIC50: 8.60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192450(US9187466, 42 | US9687476, 42)
Affinity DataIC50: 11nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192463(US9187466, 87 | US9687476, 87)
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192454(US9187466, 60 | US9687476, 60 | US10800746, Exampl...)
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192455(US9187466, 68 | US9687476, 68 | US10800746, Exampl...)
Affinity DataIC50: 12nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192456(US9187466, 71 | US9687476, 71)
Affinity DataIC50: 13nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192458(US9187466, 76 | US9687476, 76)
Affinity DataIC50: 17nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192451(US9187466, 49 | US9687476, 49)
Affinity DataIC50: 19nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192459(US9187466, 78 | US9687476, 78)
Affinity DataIC50: 23nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192445(US9187466, 9 | US9687476, 9)
Affinity DataIC50: 23nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192458(US9187466, 76 | US9687476, 76)
Affinity DataIC50: 23nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192448(US9187466, 26 | US9687476, 26)
Affinity DataIC50: 23nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192472(US9187466, 122 | US9687476, 122)
Affinity DataIC50: 27nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192467(US9187466, 101 | US9687476, 101 | US10800746, Exam...)
Affinity DataIC50: 27nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192448(US9187466, 26 | US9687476, 26)
Affinity DataIC50: 28nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192459(US9187466, 78 | US9687476, 78)
Affinity DataIC50: 29nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192469(US9187466, 111 | US9687476, 111)
Affinity DataIC50: 31nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192446(US9187466, 17 | US9687476, 17)
Affinity DataIC50: 32nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192452(US9187466, 50 | US9687476, 50)
Affinity DataIC50: 34nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192471(US9187466, 117 | US9687476, 117)
Affinity DataIC50: 39nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192457(US9187466, 74 | US9687476, 74)
Affinity DataIC50: 40nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192471(US9187466, 117 | US9687476, 117)
Affinity DataIC50: 45nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192447(US9187466, 20 | US9687476, 20)
Affinity DataIC50: 46nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192454(US9187466, 60 | US9687476, 60 | US10800746, Exampl...)
Affinity DataIC50: 50nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192445(US9187466, 9 | US9687476, 9)
Affinity DataIC50: 60nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192460(US9187466, 83 | US9687476, 83)
Affinity DataIC50: 67nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192464(US9187466, 90 | US9687476, 90)
Affinity DataIC50: 88nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192465(US9187466, 93 | US9687476, 93)
Affinity DataIC50: 89nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192465(US9187466, 93 | US9687476, 93)
Affinity DataIC50: 100nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192470(US9187466, 112 | US9687476, 112)
Affinity DataIC50: 110nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192466(US9187466, 96 | US9687476, 96)
Affinity DataIC50: 120nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192446(US9187466, 17 | US9687476, 17)
Affinity DataIC50: 120nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192447(US9187466, 20 | US9687476, 20)
Affinity DataIC50: 150nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192460(US9187466, 83 | US9687476, 83)
Affinity DataIC50: 230nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Bayer Intellectual Property

US Patent
LigandPNGBDBM192457(US9187466, 74 | US9687476, 74)
Affinity DataIC50: 260nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: